Page last updated: 2024-09-03

sr 48692 and pyrilamine

sr 48692 has been researched along with pyrilamine in 1 studies

Compound Research Comparison

Studies
(sr 48692)
Trials
(sr 48692)
Recent Studies (post-2010)
(sr 48692)
Studies
(pyrilamine)
Trials
(pyrilamine)
Recent Studies (post-2010) (pyrilamine)
2033361,86026116

Protein Interaction Comparison

ProteinTaxonomysr 48692 (IC50)pyrilamine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.13
Alpha-2A adrenergic receptorHomo sapiens (human)2.976
Cytochrome P450 2D6Homo sapiens (human)0.3
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.997
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.13
Histamine H1 receptorCavia porcellus (domestic guinea pig)0.0015
Histamine H1 receptorRattus norvegicus (Norway rat)0.0126
Sodium-dependent serotonin transporterHomo sapiens (human)0.047
Histamine H1 receptorHomo sapiens (human)0.0166
5-hydroxytryptamine receptor 2BHomo sapiens (human)2.788
Sodium-dependent dopamine transporter Homo sapiens (human)0.879
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.1
Sigma non-opioid intracellular receptor 1Homo sapiens (human)1.558

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canton, M; Gully, D; Kitabgi, P; Le Fur, G; Lespy, L; Maffrand, JP; Rostène, W1

Other Studies

1 other study(ies) available for sr 48692 and pyrilamine

ArticleYear
Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Life sciences, 1996, Volume: 58, Issue:8

    Topics: Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Histamine H1 Antagonists; Indomethacin; Injections, Intravenous; Kinetics; Male; Neurotensin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrazoles; Pyrilamine; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Substance P; Time Factors

1996